慢性肾脏病、高血压与卒中之间的相互作用:多变量孟德尔随机化分析的见解
本研究利用欧洲血统人群的全基因组关联研究数据,通过单变量、多变量及中介孟德尔随机化分析,探讨慢性肾脏病、高血压与脑血管病表型之间的因果关系。结果显示,遗传决定的较低估算肾小球滤过率与所有卒中、缺血性卒中及大动脉粥样硬化性卒中的风险独立相关,且仅小部分效应由收缩压中介。作者认为针对肾脏疾病的预防可能独立于高血压降低动脉粥样硬化性卒中风险。
要点
- 遗传决定的较低eGFR与所有卒中风险相关(OR 1.77每1-log降低)。
- 较低eGFR与大动脉粥样硬化性卒中的关联最强(OR 3.00)。
- 控制收缩压后关联仍显著,收缩压中介比例仅约6.5%-7.2%。
核心结论
- 肾功能受损(以eGFR降低评估)对卒中风险尤其是大动脉粥样硬化性卒中具有独立于收缩压的因果效应。
- 针对肾脏疾病的靶向预防可能独立于高血压降低动脉粥样硬化性卒中风险。
研究设计与样本
- 采用欧洲血统人群的全基因组关联研究数据,识别肾功能、收缩压和脑血管病的遗传代理。
- 进行单变量、多变量和中介孟德尔随机化分析,探讨肾功能对卒中风险的影响及收缩压中介的比例。
主要发现
- 单变量MR显示遗传决定的较低eGFR与所有卒中风险相关(OR 1.77,95%CI 1.31-2.40,p<0.001)。
- 单变量MR显示较低eGFR与缺血性卒中风险相关(OR 1.81,95%CI 1.31-2.51,p<0.001)。
- 单变量MR显示较低eGFR与大动脉粥样硬化性卒中风险相关(OR 3.00,95%CI 1.33-6.75,p=0.008)。
- 多变量MR控制收缩压后,较低eGFR与所有卒中(OR 1.98,95%CI 1.39-2.82,p<0.001)、缺血性卒中(OR 2.16,95%CI 1.48-3.17,p<0.001)和大动脉粥样硬化性卒中(OR 4.35,95%CI 1.84-10.27,p=0.001)的关联仍显著。
- 收缩压中介的总效应比例分别为所有卒中6.5%(0.7%-16.8%)、缺血性卒中6.6%(0.8%-18.3%)、大动脉粥样硬化性卒中7.2%(0.5%-24.8%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Chronic kidney disease (CKD) increases the risk of stroke, but the extent through which this association is mediated by hypertension is unknown. We leveraged large-scale genetic data to explore causal relationships between CKD, hypertension, and cerebrovascular disease phenotypes. METHODS: We used data from genome-wide association studies of European ancestry to identify genetic proxies for kidney function (CKD diagnosis, estimated glomerular filtration rate [eGFR], and urinary albumin-to-creatinine ratio [UACR]), systolic blood pressure (SBP), and cerebrovascular disease (ischemic stroke and its subtypes and intracerebral hemorrhage). We then conducted univariable, multivariable, and mediation Mendelian randomization (MR) analyses to investigate the effect of kidney function on stroke risk and the proportion of this effect mediated through hypertension. RESULTS: Univariable MR revealed associations between genetically determined lower eGFR and risk of all stroke (odds ratio [OR] per 1-log decrement in eGFR, 1.77; 95% CI 1.31-2.40; p < 0.001), ischemic stroke (OR 1.81; 95% CI 1.31-2.51; p < 0.001), and most strongly with large artery stroke (LAS) (OR 3.00; 95% CI 1.33-6.75; p = 0.008). These associations remained significant in the multivariable MR analysis, controlling for SBP (OR 1.98; 95% CI 1.39-2.82; p < 0.001 for all stroke; OR 2.16; 95% CI 1.48-3.17; p < 0.001 for ischemic stroke; OR 4.35; 95% CI 1.84-10.27; p = 0.001 for LAS), with only a small proportion of the total effects mediated by SBP (6.5% [0.7%-16.8%], 6.6% [0.8%-18.3%], and 7.2% [0.5%-24.8%], respectively). Total, direct and indirect effect estimates were similar across a number of sensitivity analyses (weighted median, MR-Egger regression). DISCUSSION: Our results demonstrate an independent causal effect of impaired kidney function, as assessed by decreased eGFR, on stroke risk, particularly LAS, even when controlled for SBP. Targeted prevention of kidney disease could lower atherosclerotic stroke risk independent of hypertension.
引用
- Kelly DM, Georgakis MK, Franceschini N, et al. Interplay Between Chronic Kidney Disease, Hypertension, and Stroke: Insights From a Multivariable Mendelian Randomization Analysis. Neurology. 2023. PMID: 37775316. doi:10.1212/WNL.0000000000207852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。